Learn about the world’s most advanced ex vivo immuno-oncology models.
3D-PREDICT Study to investigate potential impact to outcomes for several difficult-to-treat solid tumors…Read More
Company’s growth supports upcoming clinical programs to help better predict patient response to oncology drugs before treatment begins…Read More
Innovation milestone is a message of authentic hope for local cancer patients By Matthew Gevaert, Ph.D., and W. Jeffrey Edenfield, MD Cancer innovation and hiking the Appalachian Trail have a few things in common. Neither happens overnight; the AT typically takes five to seven months, and meaningful innovation in cancer research can take five toRead More
Staff Report – 12.14.17 The Greenville Hospital System Cancer Institute and Greenville-based KIYATEC have partnered to provide cancer patients with the diagnostic testing they need to make informed health decisions. The first of these tests to be available is one that can indicate ovarian cancer patients’ future response to chemotherapy before undergoing treatment with up to 93% accuracy, accordingRead More